These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 1480078

  • 1. Extraction of type IV collagenase/gelatinase from plasma membranes of human pancreatic cancer cells.
    Zucker S, Moll UM, Lysik RM, DiMassimo EI, Schwedes JW, Liotta LA.
    Matrix Suppl; 1992; 1():411. PubMed ID: 1480078
    [No Abstract] [Full Text] [Related]

  • 2. A new proteinase degrading type IV collagen.
    Yamagishi Y, Tsuda M, Tsuda T, Yamamura M.
    Matrix Suppl; 1992; 1():93-4. PubMed ID: 1480103
    [No Abstract] [Full Text] [Related]

  • 3. Binding and localization of M(r) 72,000 matrix metalloproteinase at cell surface invadopodia.
    Monsky WL, Kelly T, Lin CY, Yeh Y, Stetler-Stevenson WG, Mueller SC, Chen WT.
    Cancer Res; 1993 Jul 01; 53(13):3159-64. PubMed ID: 8391388
    [Abstract] [Full Text] [Related]

  • 4. 70 K type IV collagenase (gelatinase).
    Tryggvason K, Huhtala P, Höyhtya M, Hujanen E, Hurskainen T.
    Matrix Suppl; 1992 Jul 01; 1():45-50. PubMed ID: 1480085
    [Abstract] [Full Text] [Related]

  • 5. Comparative studies of a 92-kDa gelatinolytic metalloproteinase from U937 cells and matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts.
    Morodomi T, Suzuki K, Sasaguri Y, Morimatsu M, Nagase H.
    Matrix Suppl; 1992 Jul 01; 1():87-8. PubMed ID: 1480100
    [No Abstract] [Full Text] [Related]

  • 6. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro.
    Schnaper HW, Grant DS, Stetler-Stevenson WG, Fridman R, D'Orazi G, Murphy AN, Bird RE, Hoythya M, Fuerst TR, French DL.
    J Cell Physiol; 1993 Aug 01; 156(2):235-46. PubMed ID: 8344982
    [Abstract] [Full Text] [Related]

  • 7. Human neutrophil collagenase.
    Van Wart HE.
    Matrix Suppl; 1992 Aug 01; 1():31-6. PubMed ID: 1480044
    [Abstract] [Full Text] [Related]

  • 8. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
    Fridman R, Toth M, Peña D, Mobashery S.
    Cancer Res; 1995 Jun 15; 55(12):2548-55. PubMed ID: 7780967
    [Abstract] [Full Text] [Related]

  • 9. Stimulation of the 92-kD type IV collagenase promoter and enzyme expression in human melanoma cells.
    Lauricella-Lefebvre MA, Castronovo V, Sato H, Seiki M, French DL, Merville MP.
    Invasion Metastasis; 1993 Jun 15; 13(6):289-300. PubMed ID: 7860222
    [Abstract] [Full Text] [Related]

  • 10. A 92 kDa gelatinase (MMP-9) cleavage site in native type V collagen.
    Niyibizi C, Chan R, Wu JJ, Eyre D.
    Biochem Biophys Res Commun; 1994 Jul 15; 202(1):328-33. PubMed ID: 8037728
    [Abstract] [Full Text] [Related]

  • 11. Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B).
    Weeks BS, Schnaper HW, Handy M, Holloway E, Kleinman HK.
    J Cell Physiol; 1993 Dec 15; 157(3):644-9. PubMed ID: 8253876
    [Abstract] [Full Text] [Related]

  • 12. Kupffer cell-derived 95-kd type IV collagenase/gelatinase B: characterization and expression in cultured cells.
    Winwood PJ, Schuppan D, Iredale JP, Kawser CA, Docherty AJ, Arthur MJ.
    Hepatology; 1995 Jul 15; 22(1):304-15. PubMed ID: 7601425
    [Abstract] [Full Text] [Related]

  • 13. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption.
    Okada Y, Naka K, Kawamura K, Matsumoto T, Nakanishi I, Fujimoto N, Sato H, Seiki M.
    Lab Invest; 1995 Mar 15; 72(3):311-22. PubMed ID: 7898050
    [Abstract] [Full Text] [Related]

  • 14. Recombinant human 92-kDa type IV collagenase/gelatinase from baculovirus-infected insect cells: expression, purification, and characterization.
    George HJ, Marchand P, Murphy K, Wiswall BH, Dowling R, Giannaras J, Hollis GF, Trzaskos JM, Copeland RA.
    Protein Expr Purif; 1997 Jun 15; 10(1):154-61. PubMed ID: 9179302
    [Abstract] [Full Text] [Related]

  • 15. A high throughput fluorogenic substrate for interstitial collagenase (MMP-1) and gelatinase (MMP-9).
    Bickett DM, Green MD, Berman J, Dezube M, Howe AS, Brown PJ, Roth JT, McGeehan GM.
    Anal Biochem; 1993 Jul 15; 212(1):58-64. PubMed ID: 8368516
    [Abstract] [Full Text] [Related]

  • 16. Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase.
    Kataoka H, DeCastro R, Zucker S, Biswas C.
    Cancer Res; 1993 Jul 01; 53(13):3154-8. PubMed ID: 8319225
    [Abstract] [Full Text] [Related]

  • 17. Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression.
    Mackay AR, Gomez DE, Nason AM, Thorgeirsson UP.
    Lab Invest; 1994 Jun 01; 70(6):800-6. PubMed ID: 8015284
    [Abstract] [Full Text] [Related]

  • 18. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
    Dittmann KH, Lottspeich F, Ries C, Petrides PE.
    Exp Hematol; 1995 Feb 01; 23(2):155-60. PubMed ID: 7828672
    [Abstract] [Full Text] [Related]

  • 19. Metastatic NIH 3T3 x LTA cell hybrids express 72 kDa type IV collagenase.
    Xuan JW, Wilson SM, Chin JL, Chambers AF.
    Anticancer Res; 1995 Feb 01; 15(4):1227-33. PubMed ID: 7654002
    [Abstract] [Full Text] [Related]

  • 20. Matrix metalloproteinase-9 (92-kd gelatinase/type IV collagenase equals gelatinase B) can degrade arterial elastin.
    Katsuda S, Okada Y, Okada Y, Imai K, Nakanishi I.
    Am J Pathol; 1994 Nov 01; 145(5):1208-18. PubMed ID: 7977651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.